Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility
- PMID: 24752512
- DOI: 10.1002/mus.24199
Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility
Abstract
Introduction: Recent studies have identified circulating immunoglobulin (Ig) G autoantibodies against cytoplasmic 5'-nucleotidase 1A (cN1A; NT5C1A) in patients with inclusion body myositis (IBM), whose detection provides for an IBM blood diagnostic test. Whether or not anti-cN1A autoantibody isotypes other than IgG are present in IBM has not previously been reported.
Methods: Plasma and serum samples from 205 patients (50 with and155 without IBM) were studied for the presence of IgM and IgA, in addition to IgG, anti-cN1A autoantibodies using immunoblots and enzyme-linked immunoassays (ELISAs).
Results: IgM, IgA, and IgG anti-cN1A autoantibodies were detected by ELISA with similar sensitivities (49-53%) and specificities (94-96%), but with differing patterns of autoantibody isotype presence. Combination assays of all 3 autoantibody levels improved diagnostic sensitivity to 76%.
Conclusions: In addition to previously recognized IgG anti-cN1A autoantibodies, IBM patients have circulating IgM and IgA anti-cN1A autoantibodies. Differing patterns of these isotypes may be present and useful for diagnosis.
Keywords: anti-cN1A antibodies; inclusion body myositis.
Copyright © 2014 Wiley Periodicals, Inc.
Similar articles
-
Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.Ann Neurol. 2013 Mar;73(3):408-18. doi: 10.1002/ana.23840. Ann Neurol. 2013. PMID: 23596012
-
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.Ann Neurol. 2013 Mar;73(3):397-407. doi: 10.1002/ana.23822. Epub 2013 Mar 4. Ann Neurol. 2013. PMID: 23460448
-
Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.Ann Neurol. 2017 Apr;81(4):512-525. doi: 10.1002/ana.24919. Epub 2017 Apr 3. Ann Neurol. 2017. PMID: 28318044
-
Biomarkers of inclusion body myositis.Curr Opin Rheumatol. 2013 Nov;25(6):753-62. doi: 10.1097/01.bor.0000434665.75998.f5. Curr Opin Rheumatol. 2013. PMID: 24067380 Review.
-
Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis.Clin Exp Rheumatol. 2022 Feb;40(2):384-393. doi: 10.55563/clinexprheumatol/r625rm. Epub 2022 Jan 25. Clin Exp Rheumatol. 2022. PMID: 35225226 Review.
Cited by
-
Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging.Int J Mol Sci. 2024 Feb 27;25(5):2742. doi: 10.3390/ijms25052742. Int J Mol Sci. 2024. PMID: 38473988 Free PMC article. Review.
-
Uncovering the significance of expanded CD8+ large granular lymphocytes in inclusion body myositis: Insights into T cell phenotype and functional alterations, and disease severity.Front Immunol. 2023 Mar 30;14:1153789. doi: 10.3389/fimmu.2023.1153789. eCollection 2023. Front Immunol. 2023. PMID: 37063893 Free PMC article.
-
Conflicting reports of anti-cytosolic 5'-nucleotidase 1A autoantibodies in juvenile dermatomyositis: comment on the article by Rietveld et al.Arthritis Rheumatol. 2022 May;74(5):911-912. doi: 10.1002/art.42059. Epub 2022 Mar 28. Arthritis Rheumatol. 2022. PMID: 34962359 Free PMC article. No abstract available.
-
Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New.Biomolecules. 2021 Aug 20;11(8):1246. doi: 10.3390/biom11081246. Biomolecules. 2021. PMID: 34439911 Free PMC article. Review.
-
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis.Cells. 2021 May 10;10(5):1146. doi: 10.3390/cells10051146. Cells. 2021. PMID: 34068623 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
